Results 31 to 40 of about 424,058 (165)

Flow chart for 2-dose mRNA-1273 analysis cohort.

, 2022
Flow chart for 2-dose mRNA-1273 analysis cohort.
Katia J. Bruxvoort (12476079), Yun Tian (411157), Hung Fu Tseng (12476097), Ana Florea (12476073), Gina S. Lee (12476085), Jennifer H. Ku (12476088), Yi Luo (143206), Lei Qian (292302), Bradley K. Ackerson (12476082), Julia E. Tubert (12476091), Lina S. Sy (12476076), Carla A. Talarico (12476094)   +11 more
core   +1 more source

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19. [PDF]

, 2022
Importance: It has become common practice to offer immunocompromised patients with hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are scarce.
Heemskerk, Mirjam H M, Groen, Kaz, Broers, Annoek E.C., Zweegman, Sonja, Nijhof, Inger S., Beaumont, Tim, Mutsaers, Pim G. N. J., Haggenburg, Sabine, van Binnendijk, Rob S, van Binnendijk, Rob S., Bouhuijs, Joey H., Heemskerk, Mirjam H.M., Hazenberg, Mette D., Wouters, Dorine, van Leeuwen, Ester M. M., Rutten, Caroline E., Haverkate, Nienke J.E., Bhoekhan, Michel S, van Doesum, Jaap A., van Meerten, Tom, Nijhof, Inger S, Haverkate, Nienke J. E., Kater, Arnon P, Hazenberg, Mette D, Smits, Gaby P, Heemskerk, Mirjam H. M., Rutten, Caroline E, Kootstra, Neeltje A, Kater, Arnon P., Kootstra, Neeltje A., Bhoekhan, Michel S., Broers, Annoek E C, Bontkes, Hetty J., Goorhuis, Abraham, Bontkes, Hetty J, van Doesum, Jaap A, Mutsaers, Pim G N J, Bouhuijs, Joey H, van Gils, Marit J., van Gils, Marit J, Broers, Annoek E. C., Mutsaers, Pim G.N.J., Lissenberg-Witte, Birgit, Van Leeuwen, Ester M.M., Burger, Judith A, Hofsink, Quincy, van Leeuwen, Ester M M, Burger, Judith A., Lissenberg-Witte, Birgit I, Smits, Gaby P., Lissenberg-Witte, Birgit I., Haverkate, Nienke J E, den Hartog, Gerco   +52 more
core   +3 more sources

Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave

, 2023
Anti-SARS-CoV-2 vaccination of dialysis patients has been proven to be safe and effective to reduce COVID-19-related morbidity and mortality. However, data on the durability of anti-SARS-CoV-2 antibodies post-vaccination in peritoneal dialysis (PD ...
Robert Strassl, Andreas Vychytil, Florian Frommlet, Roman Reindl-Schwaighofer, Georg Beilhack, Rossella Monteforte   +5 more
core   +1 more source

Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines

Microbiology Spectrum, 2021
Studies examining antibody responses by vaccine brand are lacking and may be informative for optimizing vaccine selection, dosage, and regimens. The purpose of this study is to assess IgG antibody responses following immunization with BNT162b2 (30 μg ...
José G. Montoya, Amy E. Adams, Valérie Bonetti, Sien Deng, Nan A. Link, Suzanne Pertsch, Kjerstie Olson, Martina Li, Ellis C. Dillon, Dominick L. Frosch   +9 more
doaj   +1 more source

Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera. [PDF]

Front Immunol
IntroductionThe first vaccines approved against SARS-CoV-2, mRNA-1273 and BNT162b2, utilized mRNA platforms. However, little is known about the proteomic markers and pathways associated with host immune responses to mRNA vaccination.
Hickey TE, Mudunuri U, Hempel HA, Kemp TJ, Roche NV, Talsania K, Sellers BA, Cherry JM, Pinto LA.   +8 more
europepmc   +2 more sources

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

, 2023
The successful development of several coronavirus disease 2019 (COVID-19) vaccines has substantially reduced morbidity and mortality in regions of the world where the vaccines have been deployed.
Musk, Elon R, Cizmeci, Deniz, Collier, Ai-ris, Krammer, Florian, Dayal, Diana, Amanat, Fatima, Suscovich, Todd, Mann, Colin, Menon, Anil S, Kaplonek, Paulina, Nilles, Eric J, Rhee, Justin, Broge, Thomas, de St Aubin, Michael, Saphire, Erica Ollmann, Barouch, Dan H, Alter, Galit, Fischinger, Stephanie, Linde, Caitlyn, Lauffenburger, Douglas A   +19 more
core   +1 more source

mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients. [PDF]

Front Immunol
BackgroundCell-mediated immunity may provide durable protection against severe COVID-19, including among solid organ transplant recipients (SOTRs). This exploratory analysis in the open-label phase 3b trial evaluated cell-mediated immunity of mRNA-1273 ...
Girard B, Figueroa AL, De Rosa SC, McElrath MJ, Azzi JR, Stolman D, Siangphoe U, de Windt E, Miller JM, Das R, Priddy F.   +10 more
europepmc   +2 more sources

Table1_Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines.xlsx

, 2023
ImportanceThere is a high level of public and professional interest related to potential safety issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events were reported in phase 3 randomized controlled trials of their safety and ...
Pasquale Sessa (17445048), Kristian Hay Kragholm (13174425), Francesco Sessa (2817850), Paolo Polverino (10897845), Maurizio Sessa (3146397), Manan Pareek (738565)   +5 more
core   +1 more source

mRNA-1273 [PDF]

Reactions Weekly, 2022
  +9 more sources

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5

Vaccines, 2023
The aim of this study is to investigate the reactogenicity and immunogenicity of the fourth dose using monovalent mRNA vaccines after different three-dose regimens and to compare the 30 µg BNT162b2 and 50 µg mRNA-1273 vaccines.
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, Ritthideach Yorsaeng, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Thanunrat Thongmee, Donchida Srimuan, Thaksaporn Thatsanathorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan   +16 more
doaj   +1 more source